When a KRAS siRNA was intravenously delivered by this tumor-penetrating nanocomplex into a genetically engineered PDAC mouse model, the growth of pancreatic tumors arising from allografted KP D8-175 cells were significantly delayed. Here, KRAS is linked to neoplasm.